Global Navigation
|
|
|
|
- 2 DEC 2009
Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration - 25 NOV 2009
U.S. Food and Drug Administration Approves ABILIFY® (aripiprazole) for the Treatment of Irritability Associated with Autistic Disorder in Pediatric Patients (Ages 6 to 17 Years) - 4 AUG 2009
The European Commission Approves SAMSCA™ (tolvaptan), Europe's First and Only Oral Vasopressin Antagonist for Hyponatraemia Secondary to Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) .
- 8 SEP 2009
New addition to CalorieMate® line of balanced nutrition blocks CalorieMate® Block, Maple Flavor First new flavor in two years debuts September 29 - 26 AUG 2009
New SOYJOY Flavored with Blueberries and White Chocolate Chips SOYJOY Blueberry Debuts September 29, 2009 - 17 AUG 2009
Otsuka Pharmaceutical Supports 8th Annual Wheelchair Basketball Camp in Ibaraki held from August 14-16, 2009